NCT01889667View on ClinicalTrials.gov

Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

ORMD-0801 Dose # 1

Oral Insulin Formulation

DRUG

ORMD-0801 Dose # 2

Oral Insulin Formulation

DRUG

Placebo

Oil Capsules

Trial Locations (1)

92780

Orange County Research Center, Tustin

Sponsors

Collaborators (1)

Integrium
All Listed Sponsors
collaborator

Integrium

INDUSTRY

lead

Oramed, Ltd.

INDUSTRY

NCT01889667 - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter